Clinical Trial Update: Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating sirolimus-based, steroid-avoidance immunosuppression in African American kidney transplant recipients completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Transplantation

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: University of Michigan | Conditions: End Stage Renal Disease, Kidney Transplantation | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-04-05